Phase I/II Double Blind Randomized Trial of Lenalidomide/Dexamethasone/Anakinra vs. Lenalidomide/Dexamethasone/Placebo in Patients With Early Stage Multiple Myeloma and High Plasma Cell Growth Rate
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 06 Jul 2017
At a glance
- Drugs Anakinra (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 28 Jun 2017 Status changed from suspended to active, no longer recruiting.
- 21 Apr 2016 Status changed from not yet recruiting to recruiting.
- 07 Jan 2016 Planned initiation date changed from 1 Jul 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov